Clinical Trials Browser

Phase 2 × Carcinoma, Ductal, Breast × Pharmaceutical Preparations × Clear all

NCT01891357 2019-09-17

Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast Cancer

Phase 2 Terminated

64 enrolled 7 charts

Carcinoma, Ductal, Breast